Free Trial

Teachers Retirement System of The State of Kentucky Has $10.18 Million Holdings in Danaher Corporation (NYSE:DHR)

Danaher logo with Medical background

Teachers Retirement System of The State of Kentucky reduced its position in Danaher Corporation (NYSE:DHR - Free Report) by 38.8% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 49,645 shares of the conglomerate's stock after selling 31,536 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in Danaher were worth $10,178,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Bank Pictet & Cie Europe AG lifted its holdings in Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after buying an additional 35,730 shares in the last quarter. Proficio Capital Partners LLC lifted its holdings in shares of Danaher by 28.0% in the fourth quarter. Proficio Capital Partners LLC now owns 2,566 shares of the conglomerate's stock worth $589,000 after acquiring an additional 562 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Danaher during the fourth quarter worth $101,000. Quantbot Technologies LP acquired a new position in shares of Danaher in the fourth quarter worth approximately $2,849,000. Finally, Guardian Partners Inc. acquired a new position in shares of Danaher in the 4th quarter valued at about $4,220,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Down 1.0%

Shares of NYSE:DHR traded down $1.82 during midday trading on Monday, reaching $188.23. 5,893,907 shares of the company's stock were exchanged, compared to its average volume of 3,532,986. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The stock has a market cap of $134.71 billion, a price-to-earnings ratio of 36.55, a P/E/G ratio of 2.67 and a beta of 0.77. The firm's 50 day simple moving average is $196.13 and its two-hundred day simple moving average is $204.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Insider Transactions at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president directly owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. UBS Group decreased their target price on shares of Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Evercore ISI decreased their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Finally, Argus dropped their price target on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Three research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $248.48.

Read Our Latest Research Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines